Abstract
Compartmental models dominate epidemic modeling. Estimations of transmission parameters between compartments are typically done through stochastic parameterization processes that depend upon detailed statistics on transmission characteristics, which are economically and resource-wide expensive to collect. We apply deep learning techniques as a lower data dependency alternative to estimate transmission parameters of a customized compartmental model, for the purposes of projecting further development of the US COVID-19 epidemics. The deep learning-enhanced compartment model predicts that the basic reproduction rate (R0) will become less than one around June 18–19, 2020, and that the US “Infected” population will peak on June 17–18, 2020 at around 1·36 million individual cases. The model also predicts that the number of accumulative confirmed cases will cross the 2 million mark around June 11, 2020. It also projects that the infection transmission parameter will drop to virtually zero as early as July 8, 2020, implying that the total number of confirmed cases will likely become stabilized around that time frame (predicted at 2·23–2·24 million).
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
NA
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
NA
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Up-to-date time series data available up request.
